What is next for dried blood spots?

Bioanalysis

Volumn 4, Issue 16, 2012, Pages 2059-2065

  Ji, Qin C ^a   Liu, Guowen ^a   Darienzo, Celia J ^a   Olah, Timothy V ^a   Arnold, Mark E ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD VOLUME; DECISION MAKING; DRIED BLOOD SPOT TESTING; DRUG MONITORING; DRUG RESEARCH; HUMAN; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; MOLECULAR STABILITY; PATIENT MONITORING; REVIEW; RISK BENEFIT ANALYSIS; VALIDATION PROCESS;

BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRIED BLOOD SPOT TESTING; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PLASMA; PROTEIN BINDING; TANDEM MASS SPECTROMETRY;

EID: 84866108746     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.168     Document Type: Review

References (30)

1. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32, 338-343 (1963
2. Crossle JR, Elliot RB, Smith PA. Dried-blood screening for cystic fibrosis in the newborn. Lancet 313(8114), 472-474 (1979
3. Cassol S, Weniger BG, Babu G et al. Detection of HIV Type 1 env Subtypes A, B, C, and E in Asia using dried blood spots: A new surveillance tool for molecular epidemiology. AIDS Res. Hum. Retro. 12(15), 1435-1441 (1996
4. Sherman GG, Stevens G, Jones SA, Horsfield PMT, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J. Acq. Imm. Defic. Synd. 38(5), 615-617 (2005
5. Beaudette P, Bateman KP. Discovery stage pharmacokinetics using dried blood spots. J. Chromatog. B. 809, 153-158 (2004
6. Barfield M, Spooner N, Lad R, Parry S, Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. J. Chromatogr B. Analyt. Technol. Biomed. Life Sci. 870(1), 32-37 (2008
7. Spooner N, Lad R, Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: Considerations for the validation of a quantitative bioanalytical method. Anal. Chem. 81(4), 1557-1563 (2009
8. Evans CA, Bruce C, Emmons GT et al. DIA/ PhRMA workshop on dried blood spot sampling in the pharmaceutical industry: Methodology, implementation and best practices. Bioanalysis 2(8), 1355-1359 (2010
9. Arnaud C. Dried blood spots offer advantages, but also challenges, for pharmaceutical analysis. Chem. Eng. News 89(3), 13-17 (2011
10. Li W, Tse FL. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr. 24(1), 49-65 (2010
11. Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis 2(8), 1385-1395 (2010
12. D'Arienzo CJ, Ji QC, Discenza L et al. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis 2(8), 1415-1422 (2010
13. Liang X, Li Y, Barfield M, Ji QC. Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 877(8-9), 799-806 (2009
14. Liu G, Ji QC, Jemal M, Tymiak AA, Arnold ME. Approach to evaluating dried blood spot sample stability during drying process and discovery of a treated card to maintain analyte stability by rapid on-card pH modification. Anal. Chem. 83(23), 9033-9038 (2011
15. Spooner N. The use of dried blood spot samples for the quantitative bioanalysis of drugs in preclinical and clinical studies. Whatman Webinar (2009
16. Liu G, Patrone L, Snapp HM et al. Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays. Bioanalysis 2(8), 1405-1414 (2010
17. Liu G, Snapp HM, Ji QC. Internal standard tracked dilution to overcome challenges in dried blood spots and robotic sample preparation for liquid chromatography/ tandem mass spectrometry assays. Rapid Commun. Mass Spectrom. 25(9), 1250-1256 (2011
18. Sleczka BG, D'Arienzo CJ, Tymiak AA, Olah TV. Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC-MS-based bioanalytical methods in drug discovery. Bioanalysis 4(1), 29-40 (2012
19. Timmerman P, White S, Globig S, Lüdtke S, Brunet L, Smeraglia J. Recommendation on the validation of bioanalytical methods for dried blood spots. Bioanalysis 3(14), 1567-1575 (2011
20. Fan L, Lee JA. Managing the effect of hematocrit on DBS analysis in a regulated environment. Bioanalysis 4(4), 345-347 (2012
21. Trepanier DJ, Gallant H, Legatt DF, Yatscoff RW., Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: An update. Clin. Biochem. 31(5), 345-351 (1998
22. Emmons G, Rowland M. Pharmacokinetic considerations as to when to use dried blood spot sampling. Bioanalysis 2(11), 1791-1796 (2010
23. Hinderling P. Red blood cells: A neglected compartment in pharmacokinetics and pharmacodynamics. Pharm. Rev. 49, 3, 279-295 (1997
24. Discenza L, Obermeier MT, Westhouse R, Olah TV, D'Arienzo CJ. A bioanalytical strategy utilizing dried blood spots and LC-MS/MS in discovery toxicology studies. Bioanalysis 4(9), 1057-1064 (2012
25. Clark GT, Haynes JJ, Bayliss MA, Burrows L. Utilization of DBS within drug discovery: development of a serial microsampling pharmacokinetic study in mice. Bioanalysis 2(8), 1477-1488 (2010
26. Rahavendran SV, Vekich S, Skor H et al. Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS. Bioanalysis 4(9), 1077-1095 (2012
27. McDade TW. Williams S, Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44(4), 899-925 (2007
28. Edelbroek PM, van der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: Methods, assays, and pitfalls. Ther. Drug Monit. 31(3), 327-336 (2009
29. Wegner I, Edelbroek P, de Haan GJ, Lindhout D, Sander JW. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. Epilepsia 51(12), 2500-2502 (2010
30. Patel P, Mulla H, Tanna S, Pandya H. Facilitating pharmacokinetic studies in children: A new use of dried blood spots. Arch. Dis. Child. 95(6), 484-487 (2010